Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Aug 2000 01:25 PM
RNS
Statement re Press Comment
26 Jun 2000 08:21 AM
RNS
Research Update
06 Jun 2000 07:00 AM
RNS
Agreement
18 May 2000 11:05 AM
RNS
Agreements Signed, etc
02 May 2000 11:14 AM
RNS
Therapeutic Genes for Treatment of Cancer Acquired
31 Mar 2000 01:27 PM
RNS
Directors' Notification of Dealing in Shares
23 Mar 2000 04:29 PM
RNS
Directors' Dealings
21 Mar 2000 11:23 AM
RNS
Paul Durrands Appointed as Commercial Director
20 Mar 2000 12:08 PM
RNS
Agreement Signed with Nycomed Amersham Imaging
16 Mar 2000 08:39 AM
RNS
Human Genome/Patenting
08 Mar 2000 04:58 PM
RNS
Directors' Dealings
28 Feb 2000 08:19 AM
RNS
Gene Therapy Patent Obtained in the USA
24 Feb 2000 07:01 AM
RNS
Final Results - Year Ended 31 December 1999
21 Feb 2000 07:01 AM
RNS
Deal Signed on Novel Tumour Vaccine
14 Feb 2000 07:02 AM
RNS
Collaboration Agreement Signed with AstraZeneca
02 Feb 2000 07:01 AM
RNS
Successful Developments in Macrogen Cancer Therapy
24 Jan 2000 02:58 PM
RNS
Response to Press Comment on FDA Ruling
20 Jan 2000 04:13 PM
RNS
Holding in Company
20 Jan 2000 02:14 PM
RNS
Collaboration Agreement Signed - Replacement
20 Jan 2000 11:08 AM
RNS
Collaboration Agreement Signed with IDM
17 Jan 2000 07:01 AM
RNS
Issue of Shares
07 Jan 2000 07:01 AM
RNS
New Development in Cancer Therapy
21 Dec 1999 02:02 PM
RNS
Acquisition of Novel Antibody Technology Complete
22 Nov 1999 04:11 PM
RNS
Holding in Company
16 Nov 1999 07:14 AM
RNS
Preclinical Results - Parkinson's Disease Product
17 Aug 1999 07:30 AM
RNS
Interim Results
26 Jul 1999 09:17 AM
RNS
Directorate
UK 100